Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
基本信息
- 批准号:7167443
- 负责人:
- 金额:$ 36.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAgonistAllergicAspirinAsthmaBiologicalBiological AssayBronchial SpasmChronicChronic SinusitisCloningDataDiseaseElectrophoretic Mobility Shift AssayEndotheliumEpitheliumFeedbackFibrosisGenesGenetic TranscriptionGlandGrantHyperplasiaIndividualInflammationInflammatoryInterleukin-13Interleukin-4InterleukinsInvestigationKnockout MiceLeukotrienesLung diseasesMediatingMolecularMucous body substanceNasal PolypsOccupationsPathway interactionsProceduresProcessProductionReactionRegulationReportingResearch PersonnelRoleSignaling ProteinSinusitisSiteSyndromeTherapeuticTranscriptional RegulationUp-RegulationWorkairway remodelingbaseconceptcysteinyl leukotriene receptor 2cysteinyl-leukotrienecytokinedesensitizationeosinophilhuman IRS2 proteinin vivoleukotriene-C4 synthasepromoterreceptorreceptor expressionrespiratory smooth muscletranscription factor
项目摘要
DESCRIPTION (provided by applicant): This grant will investigate the pro-inflammatory feedback reaction that develops between interleukin (IL)-4 (and other cytokines) and cysteinyl leukotrienes (CysLTs) that leads to the inflammation, hyperplasia, and airway remodeling observed in chronic hyperplastic eosinophilic sinusitis (CHES) and asprin-exacerbated respiratory disease (AERD). AERD is a syndrome characterized by severe persistent asthma, aggressive airway remodeling, extensive hyperplastic eosinophilic sinusitis with nasal polyp (NP) formation, and intolerance to aspirin. Eosinophils are essential to the fibrotic processes associated with asthma and CHES. Aspirin intolerance reflects increased expression of leukotriene C4 synthase (LTC4S) and CysLT receptor expression and, as a result, these subjects have constitutive overproduction and heightened responsiveness to CysLTs. CysLTs function through their ability to interact with two homologous receptors: CysLTI and CysLT2 both of which are highly upregulated in AERD. We hypothesize that CysLTs contribute to the hyperplasia, fibrosis, and remodeling of AERD through their activation of eosinophils. Both the pathway responsible for CysLT synthesis and the expression of CysLT receptors are tightly regulated by cytokines, including prominently, IL-4. This pro-inflammatory feedback between CysLTs and IL-4 promotes eosinophil- mediated inflammation, mucus gland secretion, and the proliferation of airway smooth muscle, epithelium, and endothelium, leading to fibrosis. In specific aim #1 we will dissect individual roles for CysLTI and CysLT2 receptors in these processes. Our hypothesis is that whereas the CysLTI receptor may be uniquely involved in bronchospasm, the upregulation of CysLT2 receptor-dependent pathways has more important remodeling functions in CHES/AERD. Specific aim #2 will investigate the regulation of CysLT receptors and LTC4S expression by IL-4. Finally, aspirin desensitization is an effective treatment for AERD. Therefore specific aim #3 will investigate the role of IL-4 antagonism by aspirin as the therapeutic basis for the efficacy of this procedure
描述(申请人提供):这笔赠款将研究白介素4(和其他细胞因子)和半胱氨酰白三烯(CysLTs)之间的促炎反馈反应,该反应导致慢性增生性嗜酸性鼻窦炎(CHS)和阿司匹林加重的呼吸系统疾病(AERD)观察到的炎症、增殖和呼吸道重塑。AERD是一种以严重持续性哮喘、侵袭性呼吸道重塑、广泛增生性嗜酸性鼻窦炎并鼻息肉(NP)形成和阿司匹林耐受为特征的综合征。嗜酸性粒细胞在与哮喘和CHS相关的纤维化过程中是必不可少的。阿司匹林不耐受反映了白三烯C4合成酶(LTC4S)的表达增加和CysLT受体的表达,结果是,这些受试者有结构性的过量生产和对CysLts的高反应性。CysLts通过与两个同源受体CysLTI和CysLT2相互作用发挥作用,这两个受体在AERD中都高度上调。我们推测CysLTs通过激活嗜酸性粒细胞参与了AERD的增殖、纤维化和重塑。负责CysLT合成的途径和CysLT受体的表达都受到细胞因子的严格调控,尤其是IL-4。CysLTs和IL-4之间的这种促炎反馈促进了嗜酸性粒细胞介导的炎症、粘液腺分泌和气道平滑肌、上皮和内皮的增殖,从而导致纤维化。在特定的目标#1中,我们将剖析CysLTI和CysLT2受体在这些过程中的单独作用。我们的假设是,虽然CysLTI受体可能是唯一参与支气管痉挛的因素,但CysLT2受体依赖的通路上调在CHES/AERD中具有更重要的重塑功能。具体目标#2将研究IL-4对CysLT受体和LTC4S表达的调节。最后,阿司匹林脱敏是治疗AERD的有效方法。因此,具体目标#3将研究阿司匹林对IL-4的拮抗作用,作为这一过程疗效的治疗基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY C BORISH其他文献
LARRY C BORISH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY C BORISH', 18)}}的其他基金
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的持久临床和炎症反应
- 批准号:
10540527 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9893778 - 财政年份:2016
- 资助金额:
$ 36.78万 - 项目类别:
Clinical response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床反应
- 批准号:
9081696 - 财政年份:2016
- 资助金额:
$ 36.78万 - 项目类别:
Clinical immune response to rhinovirus challenge in human asthmatics
人类哮喘患者对鼻病毒攻击的临床免疫反应
- 批准号:
9075457 - 财政年份:2015
- 资助金额:
$ 36.78万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
8077929 - 财政年份:2010
- 资助金额:
$ 36.78万 - 项目类别:
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex
鼻病毒介导的哮喘的 CD4 和 CD8 T 细胞依赖性免疫机制
- 批准号:
7975934 - 财政年份:2010
- 资助金额:
$ 36.78万 - 项目类别:
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i
LTE4/LTE4 受体和 IFN-γ 与肥大细胞和嗜酸性粒细胞之间的相互作用
- 批准号:
8450125 - 财政年份:2006
- 资助金额:
$ 36.78万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7561648 - 财政年份:2006
- 资助金额:
$ 36.78万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7103793 - 财政年份:2006
- 资助金额:
$ 36.78万 - 项目类别:
Cysteinyl leukotrienes in chronic sinusitis and asthma
半胱氨酰白三烯在慢性鼻窦炎和哮喘中的作用
- 批准号:
7761238 - 财政年份:2006
- 资助金额:
$ 36.78万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 36.78万 - 项目类别:














{{item.name}}会员




